Clinical Trial Results:
            A double-blind, randomized, placebo-controlled, parallel group study of rimonabant 20 mg daily for the treatment of non-diabetic patients with nonalcoholic steatohepatitis (NASH)
    
|     Summary | |
|     EudraCT number | 2007-003012-61 | 
|     Trial protocol | PT DE BE ES HU IT FR GB | 
|     Global completion date | 
                                    27 Feb 2009
                             | 
|     Paediatric regulatory details | |
|     Is the trial part of an agreed EMA paediatric investigation plan? | 
                                        No
                                 | 
|     Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? | 
                                        No
                                 | 
|     Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? | 
                                        No
                                 | 
|     Results information | |
|     Results version number | v1(current) | 
|     This version publication date | 
                                    10 May 2016
                             | 
|     First version publication date | 
                                    10 May 2016
                             | 
|     Other versions | |
|     Summary report(s) | EFC10143 | 
            Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to            Commission Guideline 2012/C 302/03
            for further information.    
 
				
